Joint layout of early basic scientific research on digital medicine, school-enterprise cooperation
Recently, the Institute of Intelligent Medicine of Fudan University and Takeda Pharmaceutical signed a memorandum of cooperation. Both parties will give full play to their own advantages, promote early basic research and changes in the digital medical industry, and carry out innovative research and concepts from screening, diagnosis to companion treatment. Establish models and accelerate the commercialization of breakthrough results based on an evidence-based ecosystem.
In recent years, the structure of the pharmaceutical industry has been reshaped and digital medical technology has been developing rapidly. my country's biopharmaceutical industry has ushered in an opportunity for change. In July this year, Shanghai released the "Shanghai Biomedical Industry Digital Transformation Implementation Plan" to comprehensively and in-depth support the digital transformation of the biomedical industry.
Digital technology is a key element in promoting sustainable development of enterprises. In Takeda Pharmaceutical’s recent clinical trials, digital capabilities were leveraged to integrate patient and operational data and provide virtual and hybrid trial options to increase the diversity of trial participants. Medical industry personnel also call for more innovative diagnostic methods and treatments driven by digital technology, posing diversified challenges and needs for industry development.
The Fudan University Intelligent Medicine Research Institute was officially approved and established on June 30 last year. The Future Intelligent Medicine Research Institute plans to build a medical scientific research data center, including a high-performance computing platform, a health and medical data collaboration platform and an intelligent medical application service platform, to provide high-quality services for medical scientific research.
Professor Chu Yiwei, Secretary of the Party Committee of the Institute of Biomedical Sciences, Fudan University, said: The cooperation between the two parties will focus on industrial wisdom, integrate resources, explore innovative research topics and establish conceptual models, build a bridge between academia and industry, and provide better conditions for medical research and patient treatment. Deliver valuable results. Rui Jiabo, chief digital technology officer of Takeda Pharmaceutical, said: By unleashing the power of data and digitalization, promoting the digital transformation of the medical industry and exploring more innovative solutions, school-enterprise cooperation will benefit more patients.
It is reported that Fudan University Shanghai Medical College and its affiliated hospitals produce more than 1,800 patents every year, and Zhongshan Hospital alone has transformed 106 patent results in the past year. In the future, the medical school will also actively integrate into the new pattern of scientific and technological innovation and development, and give full play to its key role as the main force in basic research, the source of major scientific and technological breakthroughs, and the main position in cultivating innovative talents.
![Joint layout of early basic scientific research on digital medicine, school-enterprise cooperation](https://a5qu.com/upload/images/1fd1d64f40e4d2ef7c09f33ced8d59ac.webp)